Editor's Correspondence.

I would like to thank the following members of the editorial board who are rotating off the board for their service for the past several years: Heinrich Audebert, Antoni Dávalos, Agnes Flöel, Mikael Mazighi, Majaz Moonis, Patrik Michel, and J Mocco. I would also like to thank Scott Silverman for his contribution to the Illustrative Teaching Cases and Amytis Towfighi for her assistance with the Stroke Literature Synopses—Clinical Sciences section. The contributions of the many editorial board members and the members of the other masthead groups are invaluable for the efficient and effective functioning of Stroke. I would like to welcome the following new members to the editorial board: Lauren Beslow, Jonathan Coutinho, Gian Marco De Marchis, M. Edip Gurol, Miroslaw Janowski, Stefan Kiechl, Jennifer Majersik, Suzanne Muehlschlegel, William Whiteley, and Adrian Wong. They will provide a wide range of expertise and backgrounds to enhance the review of submitted manuscripts. In addition, I welcome Shadi Yaghi, who will assist with the Illustrative Teaching Cases, and Waleed Brinjikji, who is our new Social Media Editor. Perhaps, the most enjoyable part of my position as Editorin-Chief of Stroke is the opportunity to innovate and try new ideas to provide all types of information to our readership. As previously announced, a new section called InterSECT has begun under the leadership of Mitchell Elkind and will provide a wide range of useful articles for trainees and early career stroke physicians. In addition, a series of audio lectures with illustrative slides will be available primarily for this audience on the Stroke website. Focused Updates in Cerebrovascular Disease are another new feature under development, and the first topic will be reviews focused on various newer aspects of atrial fibrillation–related stroke. I anticipate that Stroke will publish several Focused Updates per year, so if you have suggestions for topics, please contact the Stroke office. The goal of these innovations is to enhance the utility and value of Stroke for the cerebrovascular community.